Abstract
Initial imaging evaluation of hydronephrosis of unknown etiology is a complex subject and is dependent on clinical context. In asymptomatic patients, it is often best conducted via CT urography (CTU) without and with contrast, MR urography (MRU) without and with contrast, or scintigraphic evaluation with mercaptoacetyltriglycine (MAG3) imaging. For symptomatic patients, CTU without and with contrast, MRU without and with contrast, MAG3 scintigraphy, or ultrasound of the kidneys and bladder with Doppler imaging are all viable initial imaging studies. In asymptomatic pregnant patients, nonionizing imaging with US of the kidneys and bladder with Doppler imaging is preferred. Similarly, in symptomatic pregnant patients, US of the kidneys and bladder with Doppler imaging or MRU without contrast is the imaging study of choice, as both ionizing radiation and gadolinium contrast are avoided in pregnancy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
Original language | English (US) |
---|---|
Pages (from-to) | S144-S167 |
Journal | Journal of the American College of Radiology |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2024 |
Funding
Dr DuBeau reports grants or contracts from PCOI - RELIEF trial, co- PI's Anne Cooper MD and E. Ann Gormley. Low- vs normal dose Botox for urge incontinence; payments or honoraria from Harvard Medical Schhil, CME lectures on Urinary incontinence and Benign and Malignant prostate Disease; participation on an advisory board for PROUD trial (Clinicaltrials.gov), behavioral treatment male lower tract symptoms, member and head of DSMB. No overlap. Dr Gerena reports leadership roles as Section Chief of Body Imaging. Dr Lew reports leadership roles as American Society of Nephrology Quality Committee. Dr Mankowski Gettle reports payments or honoraria from Book chapters for elsevier. Dr Oto reports consulting fees from Profound Healthcare. Dr Whitworth III reports leadership roles as - Executive Leadership Team member, Thomas F. Frist, Jr College of Medicine at Belmont University (FCoM), Faculty Assembly President, FCoM. Drs Bartel and Kraft are partners; Dr Courtney is on partnership track; and the other authors are non-partner/non-partnership track/employees.
Keywords
- AUC
- Appropriateness Criteria
- appropriate use criteria
- hydronephrosis
- initial imaging
- practice guidelines
- radiology
- unknown etiology
- urography
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging